Related Experiment Videos
Optimal timing for antihypertensive dosing: focus on valsartan
Therapeutics and Clinical Risk Management
|March 25, 2008
Summary
Optimizing hypertension treatment through chronotherapy, or timing medication based on the body's natural 24-hour rhythms, improves blood pressure control and reduces cardiovascular risk. Bedtime dosing of certain medications enhances effectiveness and minimizes side effects.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Nephrology
Background:
- Specific 24-hour blood pressure (BP) patterns are linked to target organ damage and cardiovascular events.
- The diurnal/nocturnal BP dipping pattern is a key determinant of cardiovascular risk.
- Normalizing circadian BP patterns is crucial for slowing renal injury and preventing failure.
Purpose of the Study:
- To explore the role of chronotherapy in optimizing hypertension management.
- To investigate how administration time of antihypertensive medications affects pharmacokinetics, pharmacodynamics, and clinical outcomes.
- To highlight the individualization of hypertension treatment based on circadian BP profiles.
Main Methods:
- Review of studies on the impact of administration timing for specific antihypertensive medications (nifedipine GITS, doxazosin GITS, valsartan).
- Analysis of data on dose-response curves, therapeutic coverage, and efficacy based on circadian drug administration.
- Evaluation of effects on BP dipping, patient BP control, urinary albumin excretion, and plasma fibrinogen.
Main Results:
- Bedtime dosing of nifedipine GITS is more effective and safer than morning dosing.
- Doxazosin GITS efficacy and therapeutic coverage are significantly influenced by administration time.
- Valsartan at bedtime improves BP dipping, patient BP control, and reduces urinary albumin and plasma fibrinogen.
Conclusions:
- Chronotherapy, by considering circadian BP patterns and drug pharmacokinetics/dynamics, offers a strategy to enhance antihypertensive treatment benefits.
- Individualizing treatment based on a patient's circadian BP profile can optimize BP control and reduce cardiovascular and renal risk.
- Timing of medication administration is a critical factor in achieving better outcomes in hypertension management.
Related Concept Videos
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:19Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...